Acute porphyrias - A neurological perspective.
Gerischer LM, Scheibe F, Nümann A, Köhnlein M, Stölzel U, Meisel A.
Brain Behav. 2021 Nov;11(11):e2389. doi: 10.1002/brb3.2389. Epub 2021 Oct 17.
Pathogenesis of acute encephalopathy in acute hepatic porphyria.
Pischik E, Baumann K, Karpenko A, Kauppinen R.
J Neurol. 2023 May;270(5):2613-2630. doi: 10.1007/s00415-023-11586-5. Epub 2023 Feb 9.
MR imaging of porphyric encephalopathy.
Aggarwal A, Quint DJ, Lynch JP 3rd.
AJR Am J Roentgenol. 1994 May;162(5):1218-20. doi: 10.2214/ajr.162.5.8166013.
Porphyria-induced posterior reversible encephalopathy syndrome and central nervous system dysfunction.
Jaramillo-Calle DA, Solano JM, Rabinstein AA, Bonkovsky HL.
Mol Genet Metab. 2019 Nov;128(3):242-253. doi: 10.1016/j.ymgme.2019.10.011. Epub 2019 Nov 1.
Nontransplant treatment of tyrosinemia.
Holme E, Lindstedt S.
Clin Liver Dis. 2000 Nov;4(4):805-14. doi: 10.1016/s1089-3261(05)70142-2.
Neurological manifestations of acute intermittent porphyria.
Pischik E, Kauppinen R.
Cell Mol Biol (Noisy-le-grand). 2009 Feb 16;55(1):72-83.
Reversible MRI findings of porphyric encephalopathy. A report of two cases.
Soysal A, Dogan P, Dayan C, Caliskan BG, Arpaci B.
Neuroradiol J. 2008 Dec 17;21(5):655-9. doi: 10.1177/197140090802100508. Epub 2008 Dec 17.
Diffusion-weighted magnetic resonance imaging of porphyric encephalopathy: a case report.
Yen PS, Chen CJ, Lui CC, Wai YY, Wan YL.
Eur Neurol. 2002;48(2):119-21. doi: 10.1159/000062990.
Cerebral vasospasm in acute porphyria.
Olivier P, Van Melkebeke D, Honoré PJ, Defreyne L, Hemelsoet D.
Eur J Neurol. 2017 Sep;24(9):1183-1187. doi: 10.1111/ene.13347. Epub 2017 Jul 10.
Reversible Cerebral Vasospasm in Acute Intermittent Porphyria: A Case Report and Review of the Literature.
Attout H, Guez S.
Eur J Case Rep Intern Med. 2022 Sep 12;9(9):003543. doi: 10.12890/2022_003543. eCollection 2022.
